Related Experiment Video
Updated: Sep 3, 2026
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Impact of intensive lipid modulation on angiographically defined coronary disease: clinical implications
R W Paterson1, J J Paat, G H Steele
1Division of General Internal Medicine, Duke University Medical Center, Durham, NC 27710.
Abstract:
We reviewed all randomized, controlled angiographic trials to assess the impact of intensive lipid modulation on the progression or regression of angiographically defined coronary disease. Five of seven trials satisfied selection criteria: Cholesterol-Lowering Atherosclerosis Study, Program on the Surgical Control of the Hyperlipidemias, Familial Atherosclerosis Treatment Study, Regression of Coronary Atherosclerosis During Treatment of Familial Hypercholesterolemia, and St. Thomas' Atherosclerosis Regression Study. We compared patient selection, baseline and on-trial lipid values, changes in angiographic disease scores, and clinical outcomes. In all five trials, treatment reduced levels of low-density lipoprotein (LDL) cholesterol substantially (range -32% to -46%). Treatment reduced risk of angiographic progression by almost 50% compared to controls. Furthermore, nearly one third of drug-treated patients showed angiographic regression of disease. Regression correlated well with reduction in LDL cholesterol. Although overall improvement in stenosis was modest, reduction in clinical events was impressive. Intensive lipid modulation may "stabilize" existing lesions, making them less "active" (ie, less prone to rupture or thrombosis), thereby reducing risk of acute coronary syndromes. These studies clearly support intensive lipid modulation in patients with established coronary disease.
Insights
Intensive lipid modulation significantly reduced low-density lipoprotein (LDL) cholesterol, slowing coronary disease progression by nearly 50% and enabling regression in one-third of patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Translational Research
Background:
- Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
- Effective management strategies for CAD progression are crucial.
- Lipid modulation is a key therapeutic target in cardiovascular disease.
Purpose of the Study:
- To evaluate the impact of intensive lipid modulation on coronary artery disease.
- To assess the potential for regression of angiographically defined coronary atherosclerosis.
- To analyze the relationship between lipid level reduction and clinical outcomes.
Main Methods:
- Systematic review of randomized, controlled angiographic trials.
- Inclusion of five key trials meeting selection criteria.
- Comparison of patient characteristics, lipid profiles, angiographic changes, and clinical events.
Main Results:
- Intensive lipid modulation achieved substantial reductions in low-density lipoprotein (LDL) cholesterol (-32% to -46%).
- Treatment reduced the risk of angiographic progression by approximately 50%.
- Nearly one-third of treated patients demonstrated angiographic regression of coronary disease, correlating with LDL reduction.
Conclusions:
- Intensive lipid modulation is effective in slowing CAD progression and promoting regression.
- Observed clinical benefits suggest lesion stabilization, reducing acute coronary syndrome risk.
- These findings support aggressive lipid management in patients with established coronary disease.
More Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:30Coronary Artery Disease I: Introduction
01:26Coronary Artery Disease IV: Preventive Measures
01:27Coronary Artery Disease V: Interprofessional Care
01:26Angina IV: Management
01:26Atherosclerosis III: Management